Foster City, Calif.-based drugmaker Gilead Sciences has agreed to a $5.1 billion deal with Galapagos, under which Gilead will pay to increase its stake in the Belgian biotechnology company, according to The Wall Street Journal.
Pharmacy
Many generic drugs in Medicare Part D are "wildly overpriced," according to an analysis from drug pricing research firm 46brooklyn.
Ten hospitals and health systems posted job listings seeking pharmacy leaders in the last week.
Altaire Pharmaceuticals is recalling 30 over-the-counter products sold at CVS due to sterility concerns.
Lunds & Byerlys, a supermarket chain in the Minneapolis-St. Paul region, will shut down all of its pharmacies due to significant losses, according to Fox 9.
Four drugs or medical devices approved by the FDA since July 5:
The Trump administration abandoned its proposal to overhaul the drug rebate system this week, but a host of other high-profile proposals to lower drug prices remain.
United Health Services Retail Pharmacy at Binghamton (N.Y.) General Hospital is using an automatic pill dispenser to free up pharmacist time, according to Fox affiliate WICZ.
Christi Shaw, Eli Lilly's president of biomedicines, will step down from her role in August, the drugmaker announced July 11.
Amneal Pharmaceuticals, a New Jersey generic drugmaker will close its factory in Hauppauge, N.Y., next year, eliminating 220 jobs, according to Newsday.